Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma
An imbalance of immunosuppressive cells and cytotoxic cells plays an important role in inhibiting the antitumor immune response of the tumor-bearing host. We previously reported the profiles of tumor infiltrating leukocytes in cutaneous angiosarcoma (AS) and suggested that a combination of docetaxel...
Saved in:
Main Authors: | Taku Fujimura, Yumi Kambayashi, Sadanori Furudate, Aya Kakizaki, Setsuya Aiba |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/325412 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential Use of Bisphosphonates in Invasive Extramammary Paget’s Disease: An Immunohistochemical Investigation
by: Taku Fujimura, et al.
Published: (2013-01-01) -
A Diversified Spectrometric and Molecular Docking Technique to Biophysical Study of Interaction between Bovine Serum Albumin and Sodium Salt of Risedronic Acid, a Bisphosphonate for Skeletal Disorders
by: M. Manjushree, et al.
Published: (2018-01-01) -
Synthesis of Arginase Inhibitors: An Overview
by: Maria Cristina Molaro, et al.
Published: (2025-01-01) -
Arginase-1-specific T cells target and modulate tumor-associated macrophages
by: Mads Hald Andersen, et al.
Published: (2025-01-01) -
Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
by: Yohei Asada, et al.
Published: (2019-01-01)